CIK: 1706847 - Address: C/O Black Diamond Therapeutics, Inc., One Main Street, 14Th Floor, Cambridge, MA 02142
22 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
8/10/23 16:11
8/8/23
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDS.d-1202.000-60-34116D
10/20/22 16:05
10/18/22
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDS.d-17511.700-15-11116D
9/22/22 16:40
9/20/22
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDS.d-27013.500-20-15116D
8/18/22 16:06
8/16/22
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDS.d-1,01112.640-80-41116D
7/15/21 16:01
7/13/21
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDS.dm-57019.010-30-3361D
6/17/21 16:05
6/15/21
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDS.dm-65921.970-30-3361D
5/13/21 16:43
5/11/21
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDS.dm-59719.900-30-4241D
4/15/21 17:53
4/13/21
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDS.dm-73424.460-30-4241D
2/18/21 17:49
2/16/21
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDS.dm-92529.810-31-4341D
1/21/21 17:31
1/19/21
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDS.dm-63021.010-30-4241D
12/17/20 18:01
12/15/20
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDOP,CEOS.dm-58619.530-30-4537D
11/16/18 17:17
11/15/18
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDOP,CEOS.d-19939.840-5-2119D
10/15/18 17:54
10/15/18
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDOP,CEOS.d-20841.530-5-2119D
9/19/18 19:08
9/17/18
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDOP,CEOS.d-33266.310-5-369D
8/17/18 14:59
8/15/18
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDOP,CEOS.d-27955.880-5-369D
7/17/18 16:01
7/16/18
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDOP,CEOS.d-21042.060-5-369D
5/16/18 13:37
5/15/18
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDOP,CEOS.d-34746.280-8-1000D
4/17/18 12:20
4/16/18
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDOP,CEOS.d-27036.000-8-1000D
3/16/18 10:09
3/15/18
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDOP,CEOS.d-28638.200-8-1000D
2/16/18 11:54
2/15/18
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDOP,CEOS.d-15020.000-8-1000D
1/17/18 09:48
1/16/18
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDOP,CEOS.d-17222.990-8-1000D
12/20/17 08:48
12/18/17
GTHXG1 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsVelleca Mark A.NCDOP,CEOS.d-15020.010-8-1000D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact